Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Mayur Narkhede
Assistant Professor
Close
E-mail
narkhede@uab.edu
Links
Provider Directory
LinkedIn
Visualizations
Co-author Network
Map of Science
Co-investigator Network
Mayur Narkhede
Assistant Professor
Positions
Associate Scientist
,
Experimental Therapeutics
,
O'Neal Comprehensive Cancer Center
Associate Scientist (C)
,
O'Neal Comprehensive Cancer Center
,
School of Medicine
2019 -
Assistant Professor (P)
,
Medicine - Hematology & Oncology
,
Department of Medicine
2019 -
Associate Scientist (C)
,
Center for Clinical and Translational Science (CCTS)
,
General Clinical Research Center
2020 -
Publications
Research
Background
Contact
Publications
Selected Publications
Academic Article
Filter
Year
Title
Altmetric
2020
Copanlisib in the treatment of non-Hodgkin lymphoma
.
Future Oncology
. 16:1947-1955.
2020
2020
Tafasitamab: Monoclonal antibody targeting CD19 Treatment of B-cell malignancies
.
Drugs of the future
. 45:641-651.
2020
2019
Hypertension in Patients Treated With Ibrutinib for Chronic Lymphocytic Leukemia
.
JAMA Network Open
. 2:e1916326.
2019
2019
Targeting Biology in Non-Hodgkin Lymphoma
2019
2018
Determining the sequence of novel therapies in the treatment of relapsed Hodgkin’s lymphoma
.
Expert Review of Hematology
. 11:773-780.
2018
2018
Surrogate Endpoints and Risk Adaptive Strategies in Previously Untreated Follicular Lymphoma
.
Clinical Lymphoma, Myeloma and Leukemia
. 18:447-451.
2018
2018
Primary effusion lymphoma: Current perspectives
.
OncoTargets and Therapy
. 11:3747-3754.
2018
2017
The association of histologic grade with acute graft-versus-host disease response and outcomes
.
American Journal of Hematology
. 92:683-688.
2017
2017
Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
.
PLoS ONE
. 12.
2017
2016
Incorporation of molecular data into the Revised International Prognostic Scoring System in treated patients with myelodysplastic syndromes
.
Leukemia
. 30:2214-2220.
2016
Research
Principal Investigator On
Private Grant
awarded by
Genentech
2020 - 2025
Private Grant
awarded by
TG THERAPEUTICS
2020 - 2024
Private Grant
awarded by
Gilead Sciences
2021 - 2024
Investigator On
Private Grant
awarded by
INCYTE CORPORATION
2020 - 2025
SWOG Purchase Services Agreement
awarded by
Oregon Health & Science University
2020 - 2025
Private Grant
awarded by
JUNO THERAPEUTICS
2019 - 2024
Private Grant
awarded by
TG THERAPEUTICS
2019 - 2024
Private Grant
awarded by
Genentech
2019 - 2024
ECOG-ACRIN Purchase Service Agreement
awarded by
Eastern Cooperative Oncology Group
2019 - 2024
Private Grant
awarded by
SEATTLE GENETICS, INC.
2020 - 2023
Private Grant
awarded by
Genentech
2018 - 2023
Private Grant
awarded by
SEATTLE GENETICS, INC.
2020 - 2023
Private Grant
awarded by
SEATTLE GENETICS, INC.
2020 - 2023
Private Grant
awarded by
JUNO THERAPEUTICS
2020 - 2023
Private Grant
awarded by
ASTEX PHARMACEUTICALS
2018 - 2023
Private Grant
awarded by
SEATTLE GENETICS, INC.
2018 - 2022
Private Grant
awarded by
MILLENNIUM PHARMACEUTICALS, INC.
2020 - 2022
Private Grant
awarded by
AFFIMED GMBH
2020 - 2022
Private Grant
awarded by
Genentech
2019 - 2022
Private Grant
awarded by
INNATE PHARMA
2020 - 2022
Private Grant
awarded by
JANSSEN RESEARCH & DEVELOPMENT, LLC
2014 - 2021
Private Grant
awarded by
MERCK SHARP & DOHME CORP
2015 - 2021
Private Grant
awarded by
INCYTE CORPORATION
2018 - 2021
Private Grant
awarded by
BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY
2016 - 2021
Private Grant
awarded by
F.Hoffmann-La Roche Ltd.
2015 - 2021
Private Grant
awarded by
F.Hoffmann-La Roche Ltd.
2016 - 2021
Private Grant
awarded by
Gilead Sciences
2018 - 2020
Background
Education And Training
Bachelor of Medicine & Surgery (MBBS),
Maharashtra University of Health Sciences
2012
Contact
Full Name
Mayur
Narkhede
